IL93846A0 - Endothelial cell growth factor,methods of isolation and expression - Google Patents

Endothelial cell growth factor,methods of isolation and expression

Info

Publication number
IL93846A0
IL93846A0 IL93846A IL9384690A IL93846A0 IL 93846 A0 IL93846 A0 IL 93846A0 IL 93846 A IL93846 A IL 93846A IL 9384690 A IL9384690 A IL 9384690A IL 93846 A0 IL93846 A0 IL 93846A0
Authority
IL
Israel
Prior art keywords
growth factor
factor
isolation
expression
methods
Prior art date
Application number
IL93846A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL93846A0 publication Critical patent/IL93846A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
IL93846A 1989-03-24 1990-03-22 Endothelial cell growth factor,methods of isolation and expression IL93846A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32818189A 1989-03-24 1989-03-24
US34616589A 1989-05-02 1989-05-02
US36023589A 1989-06-01 1989-06-01

Publications (1)

Publication Number Publication Date
IL93846A0 true IL93846A0 (en) 1990-12-23

Family

ID=27406587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93846A IL93846A0 (en) 1989-03-24 1990-03-22 Endothelial cell growth factor,methods of isolation and expression

Country Status (12)

Country Link
EP (1) EP0464155B1 (es)
JP (1) JP3549202B2 (es)
AT (1) ATE152626T1 (es)
AU (1) AU647737B2 (es)
CA (1) CA2050318C (es)
DE (1) DE69030660T2 (es)
DK (1) DK0464155T3 (es)
ES (1) ES2103740T3 (es)
IL (1) IL93846A0 (es)
NZ (1) NZ233067A (es)
PT (1) PT93560B (es)
WO (1) WO1990011084A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300791B2 (en) 1989-05-12 2007-11-27 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
DE69232539T3 (de) * 1992-10-28 2007-01-04 Genentech, Inc., South San Francisco Verwendung von anti-VEGF Antikörpern zur Behandlung von Krebs
CN1701814A (zh) * 1992-11-13 2005-11-30 马克斯普朗克科学促进协会 作为血管内皮生长因子受体的f1k－1
IL141687A0 (en) 1998-09-09 2002-03-10 Scios Inc Treatment of microvascular angiopathies
US7030083B2 (en) 1998-09-09 2006-04-18 University Of Washington Treatment of eclampsia and preeclampsia
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
CA2431308C (en) 2000-12-07 2010-04-13 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456550A (en) * 1982-11-22 1984-06-26 President And Fellows Of Harvard College Vascular permeability factor
US5008196A (en) * 1987-08-21 1991-04-16 Monsanto Company Stimulation of endothelial cell growth
US5240848A (en) * 1988-11-21 1993-08-31 Monsanto Company Dna sequences encoding human vascular permeability factor having 189 amino acids
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
CA2017379C (en) * 1989-05-24 2002-06-25 Kenneth A. Thomas, Jr. Purification and characterization of a glioma-derived growth factor
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor

Also Published As

Publication number Publication date
WO1990011084A1 (en) 1990-10-04
ATE152626T1 (de) 1997-05-15
CA2050318C (en) 2011-04-12
EP0464155B1 (en) 1997-05-07
PT93560B (pt) 1996-08-30
DE69030660D1 (de) 1997-06-12
CA2050318A1 (en) 1990-09-25
DE69030660T2 (de) 1997-09-25
DK0464155T3 (da) 1997-11-17
JPH04504262A (ja) 1992-07-30
JP3549202B2 (ja) 2004-08-04
NZ233067A (en) 1993-05-26
EP0464155A4 (en) 1992-05-06
EP0464155A1 (en) 1992-01-08
AU647737B2 (en) 1994-03-31
AU5565990A (en) 1990-10-22
PT93560A (pt) 1990-11-07
ES2103740T3 (es) 1997-10-01

Similar Documents

Publication Publication Date Title
CA2099138A1 (en) Chondroitinase, Process for Preparing the Same, and Pharmaceutical Composition Comprising the Same
IL93846A0 (en) Endothelial cell growth factor,methods of isolation and expression
EP0293227A3 (en) Stand mechanism for a medical optical equipment
ATE152126T1 (de) Osteogene faktoren
DK426386A (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
IT1150812B (it) Procedimento per l'ottenimento di mucopolisaccaridi biologicamente attivi, aventi purezza elevata, mediante depolimerizzazione controllata della eparina
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
FI923347A (fi) Blodfaktorer producerade med rekombinant-dna-teknik och foerfarande foer expression av naemnda blodfaktorer samt i naemnda foerfarande anvaenda rekombinanta kokoppvirus.
FR2564106B1 (fr) Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
ES2002915A6 (es) Un procedimiento para la preparacion de un peptido de veneno de serpiente que detiene el crecimiento.
DK0385391T3 (da) Ekspressionsvektorer til syntese af proteiner i Schizosaccharomyces pombe
AU3515789A (en) Composition having anti-endotoxic activity
GR3004622T3 (es)
DE3565535D1 (en) Process for the preparation of optically active 1,4-dihydropyridines
DK486988A (da) Pyridylethanolaminer, deres fremstilling og laegemidler indeholdende forbindelserne
SU674149A1 (ru) Устройство дл автоматического регулировани напр жени и компенсации реактивной мощности в узлах нагрузки
薛嘉渔 et al. STUDIES ON THE RADIOIODINATION BY IODOGEN
ES8307101A1 (es) "procedimiento para la obtencion de un preparado concentrado de factor antihemofilico de alta pureza".
ES1008755U (es) Estructura mejorada de instalaciones correctoras de deformaciones en vehiculos.
Stathopoulos Erratum for “Wind Pressure Functions for Flat Roofs”
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
IT1243931B (it) Film polimerico modificato caratterizzato da elevata barriera all'ossigeno
SU1568302A1 (ru) Держатель протеза клапана сердца
MY102245A (en) Purification of antibodies
TH4648EX (th) N,n'-ไดอัลคิลกัวนิติโนไดเพปไทด์

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
FF Patent granted
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired